Scott E. Eggener to Prostatic Neoplasms, Castration-Resistant
This is a "connection" page, showing publications Scott E. Eggener has written about Prostatic Neoplasms, Castration-Resistant.
Connection Strength
0.212
-
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19). J Clin Oncol. 2024 Apr 01; 42(10):1114-1123.
Score: 0.212